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Abstract Conventionally, ischemic heart disease (IHD)
is equated with large vessel coronary disease. However,
recent evidence has suggested a role of compromised
microvascular regulation in the etiology of IHD. Because
regulation of coronary blood flow likely involves activity
of specific ion channels, and key factors involved in
endothelium-dependent dilation, we proposed that genetic
anomalies of ion channels or specific endothelial regulators
may underlie coronary microvascular disease. We aimed to
evaluate the clinical impact of single-nucleotide polymor-
phisms in genes encoding for ion channels expressed in the
coronary vasculature and the possible correlation with IHD
resulting from microvascular dysfunction. 242 consecutive
patients who were candidates for coronary angiography
were enrolled. A prospective, observational, single-center
study was conducted, analyzing genetic polymorphisms
relative to (1) NOS3 encoding for endothelial nitric oxide
synthase (eNOS); (2) ATP2A2 encoding for the Ca2?/H?-
ATPase pump (SERCA); (3) SCN5A encoding for the
voltage-dependent Na? channel (Nav1.5); (4) KCNJ8 and
KCNJ11 encoding for the Kir6.1 and Kir6.2 subunits of
K-ATP channels, respectively; and (5) KCN5A encoding
for the voltage-gated K? channel (Kv1.5). No significant
associations between clinical IHD manifestations and
polymorphisms for SERCA, Kir6.1, and Kv1.5 were
observed (p [ 0.05), whereas specific polymorphisms
detected in eNOS, as well as in Kir6.2 and Nav1.5 were
found to be correlated with IHD and microvascular dys-
function. Interestingly, genetic polymorphisms for ion
channels seem to have an important clinical impact influ-
encing the susceptibility for microvascular dysfunction and
IHD, independent of the presence of classic cardiovascular
risk factors.
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Introduction
Historically, in the interrogation of altered vascular func-
tion in patient with ischemic heart disease (IHD), scientists
have focused their attention on the correlation between
endothelial dysfunction and atherosclerosis [11, 53, 65,
67]. However, the endothelium-independent dysfunction in
coronary microcirculation and its possible correlations with
atherosclerotic disease and myocardial ischemia have not
been extensively investigated. In normal conditions, coro-
nary blood flow regulation (CBFR) is mediated by several
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different systems, including endothelial, nervous, neuro-
humoral, myogenic, and metabolic mechanisms [2, 10, 14,
15, 63, 64, 69]. Moreover, physiologic CBFR depends also
on several ion channels, such as ATP-sensitive potassium
(KATP) channels, voltage-gated potassium (Kv) channels,
voltage-gated sodium (Nav) channels, and others. Ion
channels regulate the concentration of calcium in both
coronary smooth muscle and endothelial cells, which in
turn modulates the degree of contractile tone in vascular
muscle and the amount of nitric oxide that is produced by
the endothelium, respectively. In this context, ion channels
play a primary role in the rapid response of both the
endothelium and vascular smooth muscle cells of coronary
arterioles to the perpetually fluctuating demands of the
myocardium for blood flow [5, 6, 13, 18, 33, 45, 46, 51, 52,
61, 73, 75].
Despite this knowledge, there still exists an important
gap about the clinical relevance and causes of microvas-
cular dysfunction in IHD. By altering the overall regulation
of blood flow in the coronary system, microvascular dys-
function could alter the normal distribution of shear forces
in large coronary arteries, thus promoting atherosclerosis.
On the other hand, proximal coronary artery stenosis could
contribute to microvascular dysfunction [29, 60]. Because
ion channels play such a critical role in microvascular
endothelial and smooth muscle function, we hypothesized
that alterations of coronary ion channels could be the pri-
mum movens in a chain of events leading to microvascular
dysfunction and myocardial ischemia, independent of the
presence of atherosclerosis. Therefore, the objective of our
study was to evaluate the possible correlation between IHD
and single-nucleotide polymorphisms (SNPs) for genes
encoding several regulators involved in CBFR, including
ion channels acting in vascular smooth muscle and/or
endothelial cells of coronary arteries.
Methods
In this prospective, observational, single-center study, 242
consecutive patients admitted to our department with the
indication to undergo coronary angiography were enrolled.
All patients matched inclusion (age [18; suspected or
documented diagnosis of acute coronary syndrome or sta-
ble angina with indication(s) for coronary angiography, in
accordance with current guidelines [36, 68], and the same
ethno-geographic Caucasian origin) and exclusion criteria
(previous allergic reaction to iodine contrast, renal failure,
simultaneous genetic disease, cardiogenic shock, non-
ischemic cardiomyopathy). All patients signed an informed
consent document prior to participation in the study, which
included acknowledgement of the testing procedures to be
performed (i.e., coronary angiography; intracoronary tests;
genetic analysis, and processing of personal data). The
study was approved by the Institution’s Ethics Committee.
All clinical and instrumental characteristics were collected
in a dedicated database.
Study design
(a) Standard therapies were administered, according to
current guidelines [36, 68].
(b) In all patients, an echocardiography evaluation before
and after coronary angiography was performed.
(c) According to standard clinical practice, coronary
angiography was performed using radial artery or
femoral artery Judkins approach via sheath insertion.
(d) In patients showing normal epicardial arteries, intra-
coronary functional tests were performed through
Doppler flow wire to evaluate both endothelium-
dependent microvascular function [via intracoronary
(IC) infusion of acetylcholine (2.5–10 lg)] and non-
endothelium-dependent microvascular function [via
IC infusion of adenosine (5 lg)] [31].
(e) In all enrolled patients, a peripheral blood sample for
genetic analysis was taken.
On the basis of the coronary angiography and the intra-
coronary functional tests, the 242 patients were divided
into three groups (see also Fig. 1).
• Group 1: 155 patients with anatomic coronary alter-
ation (comprising patients with acute coronary syn-
drome and chronic stable angina).
Fig. 1 Study design: 242 consecutive not randomized patients
matching inclusion and exclusion criteria were enrolled. In all
patients, coronary angiography was performed, according to current
ESC/ACC/AHA guidelines. In patients with angiographically normal
coronary artery, intracoronary functional tests were performed. In 242
patients (155 with coronary artery disease, 46 patients with micro-
vascular dysfunction, endothelium and/or non-endothelium depen-
dent, and 41 patients with anatomically and functionally normal
coronary arteries) genetic analysis was performed
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• Group 2: 46 patients with functional coronary alteration
[normal coronary arteries as assessed by angiography,
and microvascular dysfunction defined as coronary flow
reserve (CFR) \ 2.5 after IC infusion of acetylcholine
and adenosine].
• Group 3: 41 patients with anatomically and functionally
normal coronary arteries as assessed by angiography
and with normal functional tests (CFR C 2.5 after
intracoronary infusion of acetylcholine and adenosine)
(Fig. 1).
Genetic analysis
In conformity with the study protocol, ethylenediaminete-
traacetic acid (EDTA) whole blood samples were collected
according to the international guidelines reported in the
literature [48]. Samples were transferred to the Interinsti-
tutional Multidisciplinary BioBank (BioBIM) of IRCCS
San Raffaele Pisana (Rome) and stored at -80 C until
DNA extraction.
Bibliographic research by PubMed and web tools
OMIM (http://www.ncbi.nlm.nih.gov/omim), Entrez SNP
(http://www.ncbi.nlm.nih.gov/snp), and Ensembl (http://
www.ensembl.org/index.html) were used to select variants
of genes involved in signaling pathways related to ion
channels and/or previously reported to be associated with
microvascular dysfunction and/or myocardial ischemia
and/or diseases correlated to IHD, such as diabetes
mellitus.
Polymorphisms for the following genes were analyzed:
NOS3 (endothelial nitric oxide synthase, eNOS), ATP2A2
(Ca2?/H?-ATPase pump, SERCA2), SCN5A (voltage-
dependent Na? channel, Nav1.5), KCNJ11 (ATP-sensitive
K? channel, Kir6.2 subunit), KCNJ8 (ATP-sensitive K?
channel, Kir6.1 subunit) and KCNA5 (voltage-gated K?
channel, Kv1.5). In particular, we completely analyzed by
direct sequencing exon 3 of KCNJ8 (Kir6.1 subunit), which
includes eight SNPs, as well as the whole coding region of
KCNA5 (Kv1.5 channel), which includes 32 SNPs and four
previously described variants [26, 47, 71, 72]. We also
examined the whole coding region of KCNJ11 (Kir6.2
subunit), for which sequence variants have been described
[26, 28]. All SNPs and sequence variants analyzed—a total
of 62 variants of 6 genes—are listed in Table 1.
DNA was isolated from EDTA anticoagulated whole
blood using the MagNA Pure LC instrument and the
MagNA Pure LC total DNA isolation kit I (Roche Diag-
nostics, Mannheim, Germany) according to the manufac-
turer’s instructions. Standard PCR was performed in a
GeneAmp PCR System 9700 (Applied Biosystems, CA)
using HotStarTaq Master Mix (HotStarTaq Master Mix
Kit, QIAGEN Inc, CA). PCR conditions and primer
sequences are listed in Table 1. In order to exclude pre-
analytical and analytical errors, all direct sequencing
analyses were carried out on both strands using Big Dye
Terminator v3.1 Cycle Sequencing kit (Applied Biosys-
tems), run on an ABI 3130 Genetic Analyzer (Applied
Biosystems), and repeated on PCR products obtained from
new nucleic acid extractions. All data analyses were per-
formed in a blind fashion.
Statistical analysis
This report, intended as pilot study, is the first to compare
the prevalence of SNPs in genes encoding several effectors
(including ion channels) involved in CBFR between these
groups of patients. For this reason, no definite sample size
could be formally calculated to establish a power analysis.
However, assuming a 15 % prevalence of normal macro-
vascular and microvascular coronary findings in unselected
patients undergoing coronary angiography, we estimated
that a sample size of at least 150 patients could enable the
computation of two-sided 95 % confidence intervals for
such prevalence estimates ranging between -5.0 and
?5.0 %.
The significance of the differences of observed alleles
and genotypes between groups, as well as analysis of
multiple inheritance models (co-dominant, dominant,
recessive, over-dominant and log-additive) for SNPs were
also tested using a free web-based application (http://213.
151.99.166/index.php?module=Snpstats) designed from a
genetic epidemiology point of view to analyze associa-
tion studies. Akaike Information Criterion (AIC) was
used to determine the best-fitting inheritance model for
analyzed SNPs, with the model with the lowest AIC
reflecting the best balance of goodness-of-fit and parsi-
mony. Moreover, the allelic frequencies were estimated
by gene counting, and the genotypes were scored. For
each gene, the observed numbers of each genotype were
compared with those expected for a population in Hardy–
Weinberg (HW) equilibrium using a free web-based
application (http://213.151.99.166/index.php?module=
Snpstats) [59]. Linkage disequilibrium coefficient (D0)
and haplotype analyses were assessed using the Haplo-
view 4.1 program. Statistical analysis was performed
using SPSS software package for Windows v.16.0 (SPSS
Inc., Chicago, IL).
All categorical variables are expressed as percentages,
and all continuous variables as mean ± standard deviation.
Differences between categorical variables were analyzed
by Pearson’s v2 test. Given the presence of three groups,
differences between continuous variables, including the
number of SNPs tested, were calculated using one-way
ANOVA; a post-hoc analysis with Bonferroni correction
was made for multiple comparisons.
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Table 1 All SNPs and sequence variants analyzed in the study are listed
Protein Gene OMIM SNP ID N change Amino acid
change
Primers Ta C
eNOS NOS3 163729 rs1799983 G-T Glu298Asp 50-CATGAGGCTCAGCCCCAGAAC-30 60
50-AGTCAATCCCTTTGGTGCTCAC-30




Nav1.5 SCN5A 600163 rs6599230 A-G Ala29Ala 50-CCTCTGCTCCATTGACAAGG-30
50-GCAGCCATCGAGAAGCG-30
60
rs1805124 A-G His558Arg 50-TATGAAGCCACGTTCCAGCC-30
50-CCATTGCAGTCCACAGTGC-30
Kir6.1 KCNJ8a 600935 rs11046182 A-G Intron 2 50-TCGAGATGAAACTGTTCCACC-30
50-TGCCATCTTATATGGGCATGGC-30
60
rs74069151 A-G Intron 2 50-AAGAGGTAGGCTGGATAATATCG-30
50-ATTTCCAAATAATGTTTGACCATTC-30
rs77763829 A-G Ala171Ala 50-AAGTTGGCTAGTCTTTCTGCAAGC-30
50-TTCTTGACCACCTGGATGCGCAC-30










































rs45504599 C-T Ser127Ser 50-ACCAGGCTCTGGGCACGGCG-30
50-TGGAGATGAGGATAACCAAGACCG-30
60
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Univariate and multivariate logistic regression analyses
using enter method were performed to assess the inde-
pendent impact of genetic polymorphisms on coronary
artery disease and microvascular dysfunction, while
adjusting for other confounding variables. The following
parameters were entered into the model: age, male gender,
type 2 diabetes mellitus (T2DM), systemic arterial hyper-
tension, dyslipidemia, smoking status, and family history
of myocardial infarction (MI). Only variables with a
p value \0.10 after univariate analysis were entered into
the multivariable model as covariates. A two-tailed
p \ 0.05 was considered statistically significant.
Definition of cardiovascular risk factors
Patients were classified as having T2DM if they had fasting
levels of glucose of [126 mg/dL in two separate mea-
surements or if they were taking hypoglycemic drugs.
Systemic arterial hypertension was defined as systolic
blood pressure [140 mmHg and diastolic blood
pressure [90 mmHg in two separate measurements or if
the patient was currently taking antihypertensive drugs.
Dyslipidemia was considered to be present if serum cho-
lesterol levels were[220 mg/dL or if the patient was being
treated with cholesterol-lowering drugs. Family history of
Table 1 condinued



































ND not determined, eNOS endothelial nitric oxide synthase, encoded by NOS3 gene; SERCA sarco/endoplasmic reticulum Ca2?-ATPase,
encoded by ATP2A2 gene; Nav1.5 voltage-gated Na? channel, encoded by SCN5A gene; Kir6.1 and Kir6.2 inward rectifying subunits of ATP-
sensitive K? channel, encoded by KCNJ8 and KCNJ11 genes, respectively; Kv1.5 voltage-gated K? channel, encoded by KCN5A gene. N change
nucleotide change; Ta annealing temperature (C), SNP ID Reference single-nucleotide polymorphism ID, see also http://www.ncbi.nlm.nih.gov/
snp/; OMIM# Online Mendelian Inheritance in Man, see also http://www.ncbi.nlm.nih.gov/omim/
a Complete coding exon 3
b Whole coding region
Basic Res Cardiol (2013) 108:387 Page 5 of 12
123
MI was defined as a first-degree relative with MI before the
age of 60 years.
Results
Sixty-two polymorphisms distributed among six genes
coding for nitric oxide synthase, the SERCA pump, and ion
channels were screened for sequence variations using PCR
amplification and direct DNA sequencing analysis in the
population of 155 patients with CAD (group 1), 46 patients
with microvascular dysfunction (group 2), and 41 patients
with normal coronary arteries and normal endothelium-
dependent and endothelium-independent vasodilation
(group 3). In Group 3, the genotype distribution of SNP
rs5215 (Kir6.2/KCNJ11) moderately deviates from the HW
equilibrium (p = 0.05). In Group 1 (CAD), the polymor-
phism rs6599230 of Nav1.5/SCN5A showed deviation from
HW equilibrium (p = 0.017). The genotypic distribution of
rs1799983 polymorphism for eNOS/NOS3 is inconsistent
with the HW equilibrium in groups 1, 2, and 3
(p = 0.0001, p = 0.0012 and p = 0.0001, respectively).
Haplotype analyses revealed that there is no linkage dis-
equilibrium between polymorphisms of the analyzed genes.
There was no significant difference in the prevalence of
T2DM (p = 0.185) or dyslipidemia (p = 0.271) between
groups, as shown in Table 2. In regards to genetic char-
acteristics, no significant differences between the three













Age 66.62 ± 11.935 59.38 ± 14.92 59.25 ± 10.18 0.0001
Male gender 80 % (124/155) 43.4 % (20/46) 34.1 % (14/41) 0.0001
Family history of
MI
48.3 % (75/155) 39.1 % (18/46) 19.5 % (8/41) 0.028
Hypertension 78 % (121/155) 54.3 % (25/46) 17 % (7/41) 0.0001
Type II diabetes
mellitus
30.3 % (47/155) 13 % (6/46) 34.1 % (14/41) 0.185
Dyslipidemia 51.6 % (80/155) 32.6 % (15/46) 41.4 % (17/41) 0.271
Smoking status 47 % (73/155) 23.9 % (11/46) 24.3 % (10/41) 0.030
eNOS/NOS3 – – – NS
SERCA/ATP2A2 – – – NS
Nav1.5/SCN5A – – – NS
Kir6.1/KCNJ8 – – – NS
Kir6.2/KCNJ11:
rs5215_GG
12.2 % (19/155) 8.6 % (4/46) 21.9 % (9/41) 0.041
Kir6.2/KCNJ11:
rs5219_AA
10.9 % (17/155) 10.8 % (5/46) 21.9 % (9/41) 0.019
Kv1.5/KCNA5 – – – NS
Table 3 Genetic differences comparing with ‘‘normal’’ population
Normal subjects (group 3) n = 41 Coronary artery disease (group 1) n = 155 p
(a)
Nav1.5/SCN5A: rs1805124_GG 19.5 % (8/41) 7.7 % (12/155) 0.027
Kir6.2/KCNJ11: rs5215_GG 21.9 % (9/41) 10.9 % (17/155) 0.048
Normal subjects (group 3) n = 41 Microvascular dysfunction (group 2) n = 46 p
(b)
eNOS/NOS3: rs1799983_GT 7.3 % (3/41) 26 % (12/46) 0.021
Kir6.2/KCNJ11: rs5218_CT 26.8 % (11/41) 45.6 % (21/46) 0.048
Kir6.2/KCNJ11: rs5219_AA 21.9 % (9/41) 8.7 % (4/46) 0.049
Analysis of the prevalence of SNPs among normal subjects (group 3) compared to patients with (a). CAD (group 1) and (b) microvascular
dysfunction (group 2)
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groups in terms of polymorphisms for eNOS/NOS3,
SERCA/ATP2A2, Nav1.5/SCN5A, Kir6.1/KCNJ8, or
Kv1.5/KCNA5 were noticed. However, significant differ-
ences (p \ 0.05) for the SNPs rs5215_GG, and rs5219_AA
of Kir6.2/KCNJ11 were observed, as shown in Table 2.
Table 3 displays significant differences between normal
subjects (group 3) and patients with either CAD (group 1)
or microvascular dysfunction (group 2).
When correcting for other covariates as risk factors, the
rs5215_GG genotype of Kir6.2/KCNJ11 was found to be
significantly associated with CAD after multivariate ana-
lysis (OR = 0.319, p = 0.047, 95 % CI = 0.100–0.991),
evidencing a ‘‘protective’’ role of this genotype, as shown
in Table 4a. Similarly, a trend that supports this role of
Kir6.2/KCNJ11 was also observed in microvascular dys-
function for rs5219_AA. In contrast, rs1799983_GT for
eNOS/NOS3 was identified as an independent risk factor
following multivariate analysis (Table 4b), which agrees
with literature findings as described below.
Discussion
Implications of the present work
This study describes the possible correlation of polymor-
phisms in genes encoding for CBFR effectors (i.e., ion
channels, nitric oxide synthase, and SERCA) with the
susceptibility for microcirculation dysfunction and IHD.
Our main findings are as follows:
1. A marked HW disequilibrium in the genotypic distri-
bution of rs1799983 polymorphism for eNOS/NOS3
was observed in all three populations. Moreover, this
SNP seems to be an independent risk factor for
microvascular dysfunction, as evidenced by multivar-
iate analysis;
2. The SNPs rs5215_GG, rs5218_CT, and rs5219_AA for
Kir6.2/KCJ11 could reduce susceptibility to IHD,
since they were present more frequently in patients
with anatomically and functionally normal coronary
arteries;
3. In particular, with regard to rs5215 for Kir6.2/KCJ11,
we observed a moderate deviation from the HW
equilibrium in the genotypic distribution in the control
group. In addition, this genotype appears to be an
independent protective factor in the development of
IHD, as evidenced by multivariate analysis;
4. Furthermore, the trend observed for the SNP
rs5219_AA of Kir6.2/KCNJ11 may suggest a role for
this genotype in protecting against coronary microvas-
cular dysfunction;
5. The rs1805124_GG genotype of Nav1.5/SCN5A seems
to play a role against CAD;
6. No association seems to exist between the polymor-
phisms of SERCA/ATP2A2, Kir6.1/KCNJ8, and
Kv1.5/KCNA5 and the presence IHD;
7. All groups are comparable regarding the cardiovascu-
lar risk factors of T2DM and dyslipidemia, illustrating
a potentially important implication of genetic poly-
morphisms in the susceptibility to IHD.
Table 4 Multivariate analysis
with: (a) CAD as dependent
variable and (b) microvascular
dysfunction as dependent
variable
Note that there is a trend toward
reduced prevalence of
microvascular dysfunction with
the presence of SNP
rs5219_AA. These data are
shown to emphasize the
potentially protective
association of SNPs in the
Kir6.2 subunit against IHD (see
text)
p OR 95 % CI
(a)
Age 0.002 1.065 1.024 1.109
Male gender 0.001 6.261 2.467 15.891
Family history of MI 0.009 3.625 1.389 9.460
Hypertension 0.011 3.363 1.317 8.587
Type II diabetes mellitus 0.865 2.599 0.255 9.585
Dyslipidemia 0.768 1.956 0.520 1.986
Smoking status 0.012 3.717 1.335 10.346
Kir6.2/KCNJ11: rs5215_GG 0.047 0.319 0.100 0.991
(b)
Age 0.644 0.992 0.959 1.027
Male gender 0.988 1.007 0.428 2.366
Family history of MI 0.209 0.550 0.217 1.396
Hypertension 0.087 1.506 0.215 1.193
Type II diabetes mellitus 0.597 1.351 0.443 4.120
Dyslipidemia 0.065 1.227 0.525 2.896
Smoking status 0.740 1.172 0.457 3.005
eNOS/NOS3: rs1799983_GT 0.023 5.234 1.260 8.521
Kir6.2/KCNJ11: rs5219_AA 0.055 0.260 0.066 1.028
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It is important to underline that the control group (group
3) is a high-risk population, because of their cardiovascular
risk factors (hypertension = 17 %, T2DM = 34.1 %,
dyslipidemia = 41.4 %), with an appropriate indication
for coronary angiography, in accordance with current
guidelines. Nevertheless, these patients were demonstrated
to have both anatomically and functionally normal coro-
nary arteries. Moreover, as shown in Tables 2 and 3, we
observed that rs5215_GG, rs5218_CT and rs5219_AA for
Kir6.2/KCNJ11 had a higher prevalence in this group,
compared to patients with CAD and patients with
microvascular dysfunction. Moreover, as shown in
Table 4, the presence of the rs5215_GG polymorphism
for the Kir6.2 subunit was inversely correlated with the
prevalence of cardiovascular risk factors and CAD,
whereas rs5219_AA of the Kir6.2 subunit trended towards
an inverse correlation with coronary microvascular dys-
function. On the other hand, the SNP rs1799983_GT of
eNOS was confirmed to be an independent risk factor for
microvascular dysfunction. Our data suggest that the
presence of certain genetic polymorphisms may represent
a non-modifiable protective factor that could be used to
identify individuals at relatively low-risk for cardiovas-
cular disease, regardless of the presence of T2DM and
dyslipidemia.
Current clinical and research context
In normal coronary arteries, particularly the coronary
microcirculation, there are several different mechanisms of
CBFR, including endothelial, neural, myogenic, and met-
abolic mediators [2, 8, 10, 12, 14, 15, 37, 55, 63, 64, 69]. In
particular, endothelium-dependent vasodilation acts mainly
via eNOS-derived nitric oxide (NO) in response to ace-
tylcholine and shear stress. NO increases intracellular
cyclic guanosine monophosphate. It also causes vasodila-
tion via activation of both KCa channels and KATP
channels. Recent data suggested a pathophysiologically
relevant role for the polymorphisms of eNOS/NOS3 in
human coronary vasomotion [40–43]. Our data suggest that
rs1799983_GT at exon 7 (Glu298Asp, GAG-GAT) of
eNOS/NOS3 represents an independent risk factor for
coronary microvascular dysfunction, which agrees with a
recent meta-analysis reporting an association of this SNP
with CAD in Asian populations [74]. In addition, this SNP
has been associated with endothelial dysfunction, although
the mechanisms are not well defined [30]. Consistently, a
recent study performed on 60 Indian patients with docu-
mented history of CAD reported a significantly higher
frequency of rs1799983 (p \ 0.05) compared to control
subjects, indicating that variations in NOS3 gene may
be useful clinical markers of endothelial dysfunction in
CAD [54]. Interestingly, another association between
rs1799983_GT and impaired collateral development has
been observed in patients with a high-grade coronary ste-
nosis or occlusion [19].
As is well known, the significance of the mechanisms of
CBFR is partly determined by the location within the
coronary vasculature. For instance, for vessels with a
diameter of \200 lm—which comprise the coronary
microcirculation—metabolic regulation of coronary blood
flow is considered the most important mechanism [24, 63].
Importantly, many of these mediators of metabolic regu-
lation act through specific ion channels. In particular, in
both coronary artery smooth muscle cells and endothelial
cells, potassium channels determine the resting membrane
potential (Em) and serve as targets of endogenous and
therapeutic vasodilators [9, 27]. Several types of K?
channels are expressed in the coronary tree. The KATP
channels couple cell metabolic demand to conductance, via
pore-forming (Kir6.1 and/or Kir6.2) subunits and regula-
tory [sulphonylurea-binding (SUR 1, 2A, or 2B)] subunits.
Kir6.x allows for channel inhibition by ATP, while SURx
is responsible for channel activation by ADP and Mg2?.
KATP channel activation results in an outward flux of
potassium and consequent hyperpolarization, resulting in
voltage-gated calcium channel closure, decreased Ca2?
influx, and ultimately vasodilation [1, 5, 18, 20, 21, 33, 61,
62, 73, 75].
Our data do not support any significant difference
regarding the Kir6.1 subunit of the KATP channel. On the
other hand, this study suggests an important role of specific
SNPs for the Kir6.2 subunit (Tables 2, 3)—i.e., rs5215,
rs5219, and rs5218—in the susceptibility to IHD and
microvascular dysfunction. These SNPs are among the
most studied KATP channel polymorphisms, especially in
the context of diabetes mellitus. In fact, in both Caucasian
and Asian populations, these three SNPs as well as other
genetic polymorphisms for the KCNJ11 gene have been
associated with diabetes mellitus [34, 35, 44, 50, 57,
58, 70]. Nevertheless, the precise structure–function
impacts of the various amino acid substitutions remain
unclear. The rs5215 and rs5219 polymorphisms, also
known as I337V and E23K, respectively, are highly linked
with reported concordance rates between 72 and 100 %
[22, 23, 56]. The high concordance between rs5219 and
rs5215 suggests that these polymorphisms may have orig-
inated in a common ancestor, further indicating a possible
evolutionary advantage to their maintenance in the general
population [49]. In our study, multivariate analysis sug-
gests both an independent protective role of the rs5215_GG
against developing CAD and a trend for rs5219_AA to be
associated with protection against coronary microvascular
dysfunction (Table 4a, b). The variant rs5215_GG is a
missense SNP located in the gene KCNJ11 at exon 1009
(ATC-GTC) and results in the substitution of isoleucine
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(I) residue with valine (V) [23]. Future studies are neces-
sary to better understand the influence of this single amino
acid variant on the function of the channel.
In humans, vasodilation of the coronary microvascu-
lature in response to hypoxia and KATP channel opening
are both impaired in diabetes mellitus [39]. It is also
described that gain-of-function mutations of the KCNJ11
gene cause neonatal diabetes mellitus, and loss-of-func-
tion mutations lead to congenital hyperinsulinism [43].
Our study is not discordant with previous studies about
the correlation of SNPs of the Kir6.2 subunit and dia-
betes mellitus. Rather, our findings show that these SNPs
are correlated with anatomically and functionally normal
coronary arteries, independent of the presence of either
diabetes mellitus or dyslipidemia.
These data suggest the possibility that these particular
SNPs may identify individuals with decreased risk for
coronary microcirculatory dysfunction and IHD, regardless
of the presence of T2DM and/or dyslipidemia. However,
further studies are necessary to confirm these findings. In
this context, to better investigate the implications of
genetic variation in the KATP channel, future studies
should include ion channel’s functional modification due to
the SNPs and analysis of SUR subunits.
More than 40-kV channel subunits have been identified
in the heart, and sections of human coronary smooth
muscle cells demonstrate Kv1.5 immunoreactivity [16, 17,
27, 38]. Through constant regulation of smooth muscle
tone, Kv channels contribute to the control of coronary
microvascular resistance [4, 7]. Pharmacologic molecules
that inhibit Kv1.5 channels such as pergolide [25],
4-amino-pyridine [32], and correolide [17], lead to coro-
nary smooth muscle cell contraction and block the coupling
between cardiac metabolic demand and coronary blood
flow. However, no significant differences were identified
between the study groups in terms of the particular poly-
morphisms for Kv1.5 that were analyzed in this study.
Expression of the voltage-dependent Na? channel (Nav)
has been demonstrated in coronary microvascular endothe-
lial cells [3, 66]. Our analysis reveals a possible implication
of the polymorphism rs1805124_GG for Nav1.5 channel
with the presence of anatomically and functionally normal
coronary arteries. This SNP leads to a homozygous 1673A-G
transition, resulting in a His558-to-Arg (H558R) substitu-
tion. It is important to underline that our data are the first to
correlate the polymorphism rs1805124_GG with IHD. Fur-
ther research is necessary to confirm the observed
implication.
Finally, we have analyzed the sarco/endoplasmic retic-
ulum calcium transporting Ca2?-ATPase (SERCA), which
is fundamental in the regulation of intracellular Ca2?
concentration [6]. SERCA is an intracellular pump that
catalyzes the hydrolysis of ATP coupled with the
translocation of calcium from the cytosol into the lumen of
the sarcoplasmic reticulum. Although this pump plays a
critical role in regulation of the contraction/relaxation
cycle, our analysis did not reveal any apparent association
between genetic variants of SERCA and the prevalence of
microvascular dysfunction or IHD.
Conclusions
This pilot study is the first to compare the prevalence of
SNPs in genes encoding coronary ion channels between
patients with CAD or microvascular dysfunction and those
with both anatomically and functionally normal coronary
arteries. Taken together, these results suggest the possi-
bility of associations between SNPs and IHD and micro-
vascular dysfunction, although the precise manners by
which specific genetic polymorphisms affect ion channel
function and expression have to be clarified by further
research involving larger cohorts.
Limitations and future perspectives
Notable limitations of this pilot study are as follows:
1. Due to the lack of pre-existing data, the power
calculation was performed in advance on the basis of
assumptions of allele frequencies and the population at
risk.
2. The sample size for each group is small, mainly due to
both the difficulty in enrolling patients with normal
coronary arteries and normal microvascular function
(group 3) and the elevated costs of the supplies such as
Doppler flow wires.
3. There is a lack of ethnic diversity of our cohort.
4. Currently, there is an absence of supportive findings in
another independent cohort or population. However,
our pilot study included patients within a well-defined,
specific population and was aimed to identify the
presence of statistical associations between selected
genetic polymorphisms and the prevalence of a
specific disease.
5. There is a lack of functional characterization of the
described genetic polymorphisms.
6. We have not identified any correlation between novel
SNPs and IHD. Nevertheless, we completely analyzed
exon 3 of both KCNJ8 and KCNJ11 genes (Kir6.1 and
Kir6.2 subunit, respectively) as well as the whole
coding region of KCN5A gene (Kv1.5 channel).
Moreover, we examined previously described SNPs
since there are no data in the literature regarding the
possible association of the prevalences of those
polymorphisms in the examined population.
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More extensive studies are necessary to confirm our
findings, possibly with a larger number of patients. Future
investigations are also required to confirm the roles of ion
channels in the pathogenesis of coronary microvascular
dysfunction and IHD. These studies should involve ana-
lysis of both other subunits of the KATP channels (i.e.,
sulfonylurea receptor, SURx) and further coronary ion
channels (e.g., calcium-dependent K channels), as well as
in vitro evaluation of ion channel activity by patch clamp
and analysis of channel expression in the human cardiac
tissue. Moreover, to better address the significance of
microvascular dysfunction in IHD, it could be interesting to
analyze typical atherosclerosis susceptibility genes (e.g.,
PPAP2B, ICAM1, et al.).
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